Phacilitate Leaders Forum

Women in Cell & Gene Therapy

Women in Cell & Gene Therapy

The cell and gene therapy industry is currently expanding rapidly and recruitment is becoming more of a focus for organizations, however despite expansion there is still a lack of diversity running throughout the sector. In an age when Hilary Clinton is the presidential candidate of the Democrats in the US, still only 4% of leadership roles within cell and gene therapy are held by women.

With the hope that this current recruitment drive throughout the industry will start to address this gender imbalance, Phacilitate are excited to celebrate the exceptional women already driving innovation in the sector in our new e-book:

The Most Influential Women in Cell & Gene Therapy.

#

We would like to thank Stacey Johnson of CCRM, Claudia Zylberberg of Akron Biotech and Susan Nichols of Invetech for their help in curating this e-book.


If you'd like to sign-up for updates on future events and initiatives organised by 'Women in Cell & Gene Therapy', click here.

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd

 

Show the sponsors

UPCOMING WEBINAR: Gaining Market Access in a Challenging European Environment